Skip to main content

Breadcrumb

  1. Home

A Novel, Regulated Gene Therapy (NGN-401) Study for Female Children With Rett Syndrome

Submitted by Anonymous (not verified) on Mon, 09/23/2024 - 19:57
  • Read more about A Novel, Regulated Gene Therapy (NGN-401) Study for Female Children With Rett Syndrome

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Submitted by Anonymous (not verified) on Mon, 09/23/2024 - 19:55
  • Read more about Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

Submitted by Anonymous (not verified) on Mon, 09/16/2024 - 14:46
  • Read more about VE303 for Prevention of Recurrent Clostridioides Difficile Infection

LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis

Submitted by Anonymous (not verified) on Mon, 09/16/2024 - 14:44
  • Read more about LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis

A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies

Submitted by Anonymous (not verified) on Tue, 09/10/2024 - 12:06
  • Read more about A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies

A Study to Evaluate Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy

Submitted by Anonymous (not verified) on Tue, 09/10/2024 - 12:06
  • Read more about A Study to Evaluate Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy

Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab

Submitted by Anonymous (not verified) on Tue, 09/10/2024 - 12:06
  • Read more about Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab

SEAL™IT: Saccular Endovascular Aneurysm Lattice System Interventional Pivotal Trial

Submitted by Anonymous (not verified) on Tue, 09/10/2024 - 12:05
  • Read more about SEAL™IT: Saccular Endovascular Aneurysm Lattice System Interventional Pivotal Trial

Engagement in CHildhood-Onset Systemic Lupus

Submitted by Anonymous (not verified) on Tue, 09/10/2024 - 12:05
  • Read more about Engagement in CHildhood-Onset Systemic Lupus

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Submitted by Anonymous (not verified) on Tue, 09/10/2024 - 12:05
  • Read more about MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • Page 27
  • …
  • Next page Next
  • Last page Last
Subscribe to